VaramirStart free · no cardSign in
PTCT as of Oct 31 · 10:59 ET
PTCTNasdaqPharmaceutical Preparations

PTC Therapeutics, Inc. · Brief

Next report

72 days

Jan 11est.Q4 FY26
Earnings

Expected move

Inputs

Implied vs realized

8 reportsHistory
3 of 8≥ implied
avg implied
±10.4%
avg realized
±7.6%
May 6 '25±9.6%▲+12.63%×1.31
Aug 7 '25±9.5%▼−9.89%×1.04
Nov 4 '25±12.2%▲+5.98%×0.49
Jan 12 '26±14.5%▲+0.08%×0.01
Feb 19 '26±4.3%▲+1.09%×0.26
Q1 FY26±9.4%▲+14.27%×1.51
Q2 FY26±11.6%▼−9.94%×0.85
Oct 29 '26±12.0%▼−6.97%×0.58
quarterimplied−15%0+15%realized×
Oct '26±12.0%▼−6.97%×0.58
Q2 FY26±11.6%▼−9.94%×0.85
Q1 FY26±9.4%▲+14.27%×1.51
Feb '26±4.3%▲+1.09%×0.26
Jan '26±14.5%▲+0.08%×0.01
Nov '25±12.2%▲+5.98%×0.49
2 older reports
Aug '25±9.5%▼−9.89%×1.04
May '25±9.6%▲+12.63%×1.31
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Jan 11 report · est.

—

Linked exposure

PTCT report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 15impliedImplied move: ±11.9% into Oct 29 earnings (Oct 15 close).Source
Oct 15report dateEarnings date confirmed: Oct 29, after close.Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.